SAN JOSE, Calif.–(BUSINESS WIRE)– #PT–VS3 Medical announced the first patients enrolled in first-in-human study evaluating VS3 Medical™ Stent System for symptomatic venous sinus stenosis.
Tag: VS3
Recent
Rapid Medical™ Announces FDA Clearance of TIGERTRIEVER™ 25 and First Clinical Cases
ACHIEVE-4, the longest Phase 3 study of Lilly’s Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health
Nicklaus Children’s Hospital’s Heart Institute Performs Florida’s First Partial Heart Transplant
Popular
- No commented posts yet